Using immunotherapy wisely for prostate cancer
Only a small minority of prostate cancer patients benefit from immunotherapy. Gerhardt Attard, MD, PhD, FRCP, of the Royal Marsden NHS Foundation Trust, London, UK, spoke to us at the UK Oncology Foru...
Author: VJOncology
Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts
Liquid vs. tissue biopsies for prostate cancer
The molecular signatures of tumor cells are often used to select patients for clinical trial recruitment. In this video, Gerhardt Attard, MD, PhD, FRCP, of the Royal Marsden NHS Foundation Trust, Lond...
Author: VJOncology
Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts
Outcomes from the PROSPER and SPARTAN studies at ASCO 2018
Celestia S. Higano, MD, shares the outcomes from the PROSPER and SPARTAN studies in non-metastatic castrate-resistant prostate cancer are impacting the standard of care at ASCO 2018
Author: obr
Added: 07/17/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 17, 2018 Category: Cancer & Oncology Source Type: podcasts
How MRI has improved the diagnosis of prostate cancer
Celestia S. Higano, MD, shares how MRIs improved the diagnosis for prostate cancers at ASCO 2018.
Author: obr
Added: 07/17/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 17, 2018 Category: Cancer & Oncology Source Type: podcasts
Imaging as a cost-effective solution for diagnosis of prostate cancer
Celestia S. Higano, MD, talks about imaging as a cost-effective solution for diagnosis of prostate cancer at ASCO 2018
Author: obr
Added: 07/17/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 17, 2018 Category: Cancer & Oncology Source Type: podcasts
Robert Dreicer, MD, MS, MACP, FASCO - Newest Advances and Strategies in Prostate Cancer: Science and Stories on the Evolving Treatment Landscape and Implications for Patient Care
Newest Advances and Strategies in Prostate Cancer: Science and Stories on the Evolving Treatment Landscape and Implications for Patient Care (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - July 16, 2018 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
African Americans with prostate cancer respond better to abiraterone than Caucasians
The androgen synthesis inhibitor abiraterone increases the survival of men with metastatic prostate cancer; however, existing clinical trials consistently over-represent Caucasian men. Here, Andrew Ar...
Author: VJOncology
Added: 07/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 16, 2018 Category: Cancer & Oncology Source Type: podcasts
Osteomimicry in prostate cancer: current understanding & amp; future targeting
Osteomimicry has been studied for the last few decades, and is the process by which cancer cells can spread to the bone and evade immune surveillance. Here, Andrew Armstrong, MD, from Duke University,...
Author: VJOncology
Added: 07/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Robert Dreicer, MD, MS, MACP, FASCO, MD - Science and Stories: Navigating the Prostate Cancer Landscape: Urologists at the Intersection of Emerging Evidence and Patient Centric Care
Science and Stories: Navigating the Prostate Cancer Landscape: Urologists at the Intersection of Emerging Evidence and Patient Centric Care (Source: PeerView CME/CE Audio Podcast - Primary Care)
Source: PeerView CME/CE Audio Podcast - Primary Care - July 2, 2018 Category: Primary Care Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Radical surgery for oligometastatic prostate cancer
The TroMBone trial (ISRCTN15704862), comparing radical prostatectomy with systemic therapy vs. systemic therapy alone in men with oligometastatic prostate cancer, is currently underway in the UK, with...
Author: VJOncology
Added: 06/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Underserved & amp; Underrepresented Patient Population African-Americans have higher risk of prostate cancer
Heather H. Cheng MD, PhD, Seattle Cancer Care Alliance, discusses Underserved & Underepresented Patient Population African-Americans have higher risk of prostate cancer at ASCO 2018.
Author: Annual-Meeting
Added: 06/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Gentlemen's Study for Metastatic Prostate Cancer Trial offers testing in a web-based, phone-based manner
Heather H. Cheng MD, PhD, Seattle Cancer Care Alliance, discusses Gentlemen's Study for Metastatic Prostate Cancer Trial offers testing in a web-based, phone-based manner at ASCO 2018.
Author: Annual-Meeting
Added: 06/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2018 Category: Cancer & Oncology Source Type: podcasts
New Treatments for Prostate Cancer Identified from Tumor & amp; Germline or Inherited sequencing
Heather H. Cheng MD, PhD, Seattle Cancer Care Alliance, discusses New Treatments for Prostate Cancer Identified from Tumor & Germline or Inherited sequencing at ASCO 2018.
Author: Annual-Meeting
Added: 06/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2018 Category: Cancer & Oncology Source Type: podcasts
USPSTF Recommendation: Screening for Prostate Cancer
Interview with Alex H Krist, MD, MPH, Task Force member and co-author of Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - May 8, 2018 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Water Intake and CKD Progression, Vasopressin and Afib in Shock, New Prostate Cancer Screening Guideline, and more
Editor's Summary by Edward Livingston, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the May 08, 2018 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - May 8, 2018 Category: General Medicine Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts
